• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Nat.Immunol. Influenza-induced monocyte-derived alveolar macrophages confer prolonged antibacterial protection

tetano

Editor, Senior Moderator
Nat Immunol. 2020 Jan 13. doi: 10.1038/s41590-019-0568-x. [Epub ahead of print] [h=1]Influenza-induced monocyte-derived alveolar macrophages confer prolonged antibacterial protection.[/h]
Aegerter H[SUP]1[/SUP], Kulikauskaite J[SUP]1[/SUP], Crotta S[SUP]1[/SUP], Patel H[SUP]2[/SUP], Kelly G[SUP]2[/SUP], Hessel EM[SUP]3[/SUP], Mack M[SUP]4[/SUP], Beinke S[SUP]3[/SUP], Wack A[SUP]5[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] Despite the prevalence and clinical importance of influenza, its long-term effect on lung immunity is unclear. Here we describe that following viral clearance and clinical recovery, at 1 month after infection with influenza, mice are better protected from Streptococcus pneumoniae infection due to a population of monocyte-derived alveolar macrophages (AMs) that produce increased interleukin-6. Influenza-induced monocyte-derived AMs have a surface phenotype similar to resident AMs but display a unique functional, transcriptional and epigenetic profile that is distinct from resident AMs. In contrast, influenza-experienced resident AMs remain largely similar to naive AMs. Thus, influenza changes the composition of the AM population to provide prolonged antibacterial protection. Monocyte-derived AMs persist over time but lose their protective profile. Our results help to understand how transient respiratory infections, a common occurrence in human life, can constantly alter lung immunity by contributing monocyte-derived, recruited cells to the AM population.


PMID: 31932810 DOI: 10.1038/s41590-019-0568-x
 
Back
Top Bottom